Medison is a global pharma company focused on providing access to highly innovative therapies in international markets, helping to save and improve the lives of patients suffering from the most challenging diseases

Meir Jakobsohn, Founder and CEO

A letter from our Founder & Executive Chairman, Meir Jakobsohn


Imagine this, two children, born on the same day are diagnosed with the same severe and rare illness. Despite the similarity, they will face very different odds of surviving just because of where they live in the world. Medison was created out of a patient-centric mission to save lives by bridging this life-threatening market access gap in international markets.

As third generation in the pharma industry, I deeply understand the nature of the pharma industry, the evolution it has undergone over the decades, as well as patterns and trends. These insights, together with my passion for medical innovation and desire to bring it to people who need it the most, are the key drivers that led me to found Medison in 1996 and grow it to become a global pharma company.

At Medison, we embrace the spirit of being ‘Always Ahead’. We carry out our mission to save lives of patients in international markets through our focused and continuous efforts to lead, innovate and keep moving forward. We act in concert across regions to reach more patients, in more countries and provide them with faster access to highly innovative therapies.

We believe that every patient, everywhere, has the right to get access to breakthrough treatments and we are here to make this happen.


Meir Jakobsohn, Founder and Executive Chairman

Facts and


The year Medison was established


Employees worldwide and growing!


Lives covered by direct operations across regions


Operating in more than 30 countries across 5 continents


To create the category of multi-regional partner for highly innovative therapies


Women employed in the company

Medison Pharma About Us

We believe that all patients, wherever they are in the world, have the right to get access to the best available novel treatments, and we are here to make this happen

Our Guiding


At the core of every action we take is our commitment to help save and improve the lives of patients, around the world, who suffer from the most challenging diseases


We are always on the look-out for the most innovative, best in class therapies that have a substantial positive impact on patients’ lives


We think fast and act quickly. We know how to swiftly set-up new processes, ad-hoc teams and new infrastructure. Our flexible nature helps us to stay ahead of the curve and ensure patient-oriented solutions

Always Ahead

We create value for our partners here and now, while keeping our finger on the pulse to anticipate future market needs, scientific breakthroughs, regulatory changes and  healthcare trends


Meir Jakobsohn, Founder and CEO
Meir Jakobsohn
Founder & Executive Chairman
Gil Gurfinkel, VP Global Corporate Development & Head of International Markets
Gil Gurfinkel
Chief Executive Officer
Ron Goldstein VP Finance
Ron Goldstein
Chief Financial Officer
Gil Herling
Chief Operating Officer
Victor Papamoniodis
Victor Papamoniodis
Chief Commercial Officer
Anat Shenkar, VP HR
Anat Shenkar
Chief People Officer
Yoel Lipschitz, VP Regulatory Affairs & Market Access
Yoel Lipschitz
SVP Market Access
Ilan Kochba
VP Medical Affairs
Matan Ofir
VP Business Development
Sarah Otten
VP, GM Medison Americas
Ofir Tessel, VP Information & Business Technology
Ofir Tessel
VP Information & Business Technology
Yael Zidky, VP Compliance
Yael Zidky
VP Compliance
Silven Zohar
VP, GM Medison Israel